PUBLICATION ALERT! “Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia” in British Medical Journal
A new paper authored by the LDN Trial team has been published in the scientific journal British Medical Journal, entitled “Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia” The paper outlines the protocol for the LDN Clinical Trial which will assess the efficacy of low dose […]
Congratulations to Dr. Luis Nacul & Team for receiving CIHR Project Grant 2024 Priority Announcement!
We are thrilled to announce that Dr. Luis Nacul and Co-Investigators Dr. Kathleen Kerr, Dr. Hilary Robertson & Dr. Zaya Chuluunbaatar have been awarded the CIHR Project Grant PA: Pandemic Preparedness and Health Emergencies Research. This grant will support new study called “Epidemiology and impact of myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS) in Canada: […]
Congrats to CCDP Team on receiving ICanCME New Frontiers Grant!
CCDP Post-Doctoral Research Fellow, Dr. Zaya Chuluunbaatar and Principal Investigator Dr. Luis Nacul were selected as recipients of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis (ICanCME) Research Network 2023/2024 New Frontiers ME Discovery Grant Program Award. This award will support the project “Phenotyping Questionnaires Validation Study for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome” which will evaluate whether three patient-reported […]